Acetylcholine-induced endothelium-derived contracting factor in hypoxic pulmonary hypertensive rats

Journal of Applied Physiology

Volumn 86, Issue 5, 1999, Pages 1687-1695

  Maruyama, Junko ^a   Yokochi, Ayumu ^a   Maruyama, Kazuo ^a   Nosaka, Shoichiro ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chronic hypoxia; Nitric oxide; Prostaglandin H2; Thromboxane A2

Indexed keywords

15 CYCLOPENTYL 14 OXO 13 AZA 16,17,18,19,20 PENTANORPINANE THROMBOXANE A2; ACETYLCHOLINE; ENDOTHELIUM DERIVED CONSTRICTING FACTOR; ISBOGREL; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; OZAGREL; PERHYDRO 1 AZEPINYLCARBONYLLEUCYL DEXTRO TRYPTOPHYL DEXTRO TRYPTOPHAN; PROSTAGLANDIN H2; SUPEROXIDE DISMUTASE; THROMBOXANE A2 RECEPTOR BLOCKING AGENT;

ANIMAL MODEL; ANIMAL TISSUE; ARTERY DILATATION; ARTERY ENDOTHELIUM; ARTERY TONE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; HEART RIGHT VENTRICLE HYPERTROPHY; HYPOXIA; MALE; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAT;

EID: 0032951303     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/jappl.1999.86.5.1687     Document Type: Article

References (34)

1. Adnot, S., B. Raffestin, S. Eddahibi, P. Braquet, and P. E. Chabrier. Loss of endothelium-dependent relaxant activity in the pulmonary circulation of rats exposed to chronic hypoxia. J. Clin. Invest. 87: 155-162, 1991.
2. Bank, N., and H. S. Aynedjian. Role of thromboxane impaired renal vasodilation response to acetylcholine in hypercholesterolemic rats. J. Clin. Invest. 89: 1636-1642, 1992.
3. Christman, B. W., C. D. McPherson, J. H. Newman, G. A. King, G. R. Bernard, B. M. Groves, and J. E. Loyd. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N. Engl. J. Med. 327: 70-75, 1992.
4. Coleman, R. A., W. L. Smith, and S. Narumiya. International union of pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol. Rev. 46: 205-229, 1994.
5. Dinh-Xuan, A. T., T. W. Higenbottam, C. A. Clelland, J. Pepke-Zaba, G. Cremona, A. Y. Butt, S. R. Large, F. C. Wells, and J. Wallwork. Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease. N. Engl. J. Med. 324: 1539-1547, 1991.
6. 2 are contractile factors in intrarenal arteries of spontaneously hypertensive rats. Hypertension 19: 795-798, 1992.
7. 2 in the SHR aorta. Circ. Res. 76: 1003-1010, 1995.
8. Hattori, Y., H. Kawasaki, K. Abe, and M. Kanno. Superoxide dismutase recovers altered endothelium-dependent relaxation in diabetic rat aorta. Am. J. Physiol. 261 (Heart Circ. Physiol. 30): H1086-H1094, 1991.
9. Isaacson, T. C., V. Hampl, E. K. Weir, D. P. Nelson, and S. L. Archer. Increased endothelium-derived NO in hypertensive pulmonary circulation of chronically hypoxic rats. J. Appl. Physiol. 76: 933-940, 1994.
10. Ishikawa, K., M. Ihara, K. Noguchi, T. Mase, N. Mino, T. Saeki, T. Fukuroda, T. Fukami, S. Ozaki, T. Nagase, M. Nishikibe, and M. Yano. Biochemical and pharmacological profile of a potent and selective endothelin β-receptor antagonist, BQ-788. Proc. Natl. Acad. Sci. USA 91: 4892-4896, 1994.
11. Itou, S., T. Sasaki, K. Ide, K. Ishikawa, M. Nishikibe, and M. Yano. A novel endothelin ETA receptor antagonist, BQ-485, and its preventive effect on experimental cerebral vasospasm in dogs. Biochem. Biophys. Res. Commun. 195: 969-975, 1993.
12. Katsura, M., T. Miyamoto, N. Hamanaka, K. Kondo, T. Terada, Y. Ohgaki, A. Kawasaki, and M. Tsuboshima. In vitro and in vivo effects of new powerful thromboxane antagonists. Adv. Prostaglandin Thromboxane Leukot. Res. 11: 351-357, 1983.
13. Largo, R., D. Gomez-Garre, X. H. Liu, J. Alonso, J. Blanco, J. J. Plaza, and J. Egido. Endothelin-1 upregulation in the kidney of uninephrectomized spontaneously hypertensive rats and its modification by the angiotensin-converting enzyme inhibitor quinapril. Hypertension 29: 1178-1185, 1997.
14. Lerman, A., D. R. Holmes, M. R. Bell, K. N. Garratt, R. A. Nishimura, and J. C. Burnett. Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans. Circulation 92: 2426-2431, 1995.
15. Li, H., S. Chen, Y. Chen, Q. C. Meng, J. Durand, S. Oparil, and T. S. Elton. Enhanced endothelin-1 and endothelin receptor gene expression in chronic hypoxia. J. Appl. Physiol. 77: 1451-1459, 1994.
16. Maruyama, J., and K. Maruyama. Impaired nitric oxide-dependent responses and their recovery in hypertensive pulmonary arteries of rats. Am. J. Physiol. 266 (Heart Circ. Physiol. 35): H2476-H2488, 1994.
17. Maruyama, K., C. Ye, M. Woo, H. Venkatacharya, L. D. Lines, M. M. Silver, and M. Rabinovitch. Chronic hypoxic pulmonary hypertension in rats and increased elastolytic activity. Am. J. Physiol. 261 (Heart Circ. Physiol. 30): H1716-H1726, 1991.
18. 2 in responses of cerebral arterioles during chronic hypertension. Am. J. Physiol. 262 (Heart Circ. Physiol. 31): H539-H543, 1992.
19. Mayhan, W. G., L. K. Simmons, and G. M. Sharpe. Mechanism of impaired responses of cerebral arterioles during diabetes mellitus. Am. J. Physiol. 260 (Heart Circ. Physiol. 29): H319-H326, 1991.
20. 2-stimulated mitogenesis of coronary artery smooth muscle cells involves activation of mitogen-activated protein kinase and S6 kinase. J. Biol. Chem. 269: 5693-5698, 1994.
21. Orton, E. C., J. T. Reeves, and K. R. Stenmark. Pulmonary vasodilation with structually altered pulmonary vessels and pulmonary hypertension. J. Appl. Physiol. 65: 2459-2467, 1988.
22. Owen, N. E. Prostaglandin can inhibit DNA synthesis in vascular smooth muscle cells. In: Prostaglandins, Leukotrienes and Lipoxins, edited by J. M. Bailey. New York: Plenum, 1985, p. 193-204.
23. Rabinovitch, M., W. Gamble, A. S. Nadas, O. S. Miettinen, and L. Reid. Rat pulmonary circulation after chronic hypoxia: hemodynamic and structural features. Am. J. Physiol. 236 (Heart Circ. Physiol. 5): H818-H827, 1979.
24. Rabinovitch, M., M.A. Konstam, W. J. Gamble, N. Papanicolaou, M. J. Aronovitz, S. Treves, and L. Reid. Changes in pulmonary blood flow affect vascular response to chronic hypoxia in rats. Circ. Res. 52: 432-441, 1983.
25. Rabinovitch, M., M. Mullen, H. C. Rosenberg, K. Maruyama, H. O'Brodovich, and P. M. Olley. Angiotensin II prevents hypoxic pulmonary hypertension and vascular changes in rat. Am. J. Physiol. 254 (Heart Circ. Physiol. 23): H500-H508, 1988.
26. Shaul, P. W., B. Kinane, M. A. Farrar, L. M. Buja, and R. R. Magness. Prostacyclin production and mediation of adenylate cyclase activity in the pulmonary artery. J. Clin. Invest. 88: 447-455, 1991.
27. 2 as an endothelium-derived contracting factor in diabetic state. Diabetes 42: 1246-1252, 1993.
28. Stelzner, T. J., R. F. O'Brien, M. Yanagisawa, T. Sakurai, K. Sato, S. Webb, M. Zamora, I. F. McMurtry, and J. H. Fisher. Increased lung endothelin-1 production in rats with idiopathic pulmonary hypertension. Am. J. Physiol. 262 (Lung Cell. Mol. Physiol. 6): L614-L620, 1992.
29. Tagawa, H., H. Tomoike, and M. Nakamura. Putative mechanisms of the impairment of endothelium-dependent relaxation of the aorta with atheromatous plaque in heritable hyperlipidemic rabbits. Circ. Res. 68: 330-337, 1991.
30. 2 synthase inhibitor. Thromb. Res. 41: 223-237, 1986.
31. Tesfamariam, B., and R. A. Cohen. Role of superoxide anion and endothelium in vasoconstrictor action of prostaglandin endoperoxide. Am. J. Physiol. 262 (Heart Circ. Physiol. 31): H1915-H1919, 1992.
32. 2. Am. J. Physiol. 257 (Heart Circ. Physiol. 26): H1327-H1333, 1989.
33. Vanderhoek, J. Y., and J. M. Bailey. Activation of a 15-lipoxygenase/leukotriene pathway in human polymorphonuclear leukocytes by the anti-inflammatory agent ibuprofen. J. Biol. Chem. 259: 6752-6756, 1984.
34. Vezza, R., G. G. Nenci, and P. Gresele. Thromboxane synthase inhibitors supress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets: role of adenylylcyclase up-regulation. J. Pharmacol. Exp. Ther. 275: 1497-1505, 1995.